Bioinformatics analysis based on the Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases showed that (15) TMEM200A could be used to construct a risk score for the prognosis of acute myeloid leukemia (AML) and could effectively predict the OS of patients with AML. This evidence concerns the gene TMEM200A and acute myeloid leukemia.